Topical Anti-Inflammatory Formulations from Medicinal Plant Extracts: Stability, Efficacy, and Cytokine Modulation in a Carrageenan-Induced Paw Edema Model

Background: Traditional anti-inflammatory drugs, like NSAIDs, often cause side effects, which has fueled interest in plant-based alternatives with fewer adverse effects. Medicinal plants such as turmeric (Curcuma longa), ginger (Zingiber officinale), frankincense (Boswellia serrata), ashwagandha (Withania somnifera), and gotu kola (Centella asiatica) are known for their bioactive compounds with anti-inflammatory properties. This study aimed to evaluate the anti-inflammatory efficacy of these plant extracts in topical formulations. Methods: Ethanol extracts of the selected plants were prepared and formulated into topical gel and cream forms. Stability testing was conducted over a 30-day period to confirm the formulations' consistency, color, and pH. Anti-inflammatory efficacy was assessed using a carrageenan-induced paw edema model in Wistar rats. The animals were divided into six groups, including control, standard drug (indomethacin), and plant-based formulations at two extract concentrations (5% and 10%). Edema reduction was measured using a plethysmometer, and serum cytokine levels (TNF-α and IL-6) were quantified via ELISA. Histopathological analyses of tissue samples further evaluated the anti-inflammatory effects. Results: Both gel and cream formulations demonstrated stability over 30 days. The 10% extract cream formulation achieved the highest reduction in paw edema (70%) and reduced inflammation levels comparable to indomethacin. The 10% extract gel showed similar results (65% reduction). Biochemical analysis revealed significant reductions in TNF-α and IL-6 levels, especially in the 10% cream and gel groups, aligning with histopathological findings that indicated reduced tissue damage and inflammatory cell infiltration in treated groups compared to controls. Conclusion: The findings suggest that these plant extracts possess potent anti-inflammatory effects when formulated into stable, topical products. The 10% extract cream formulation was particularly effective, offering a promising alternative for managing inflammation with fewer side effects.

Publication Details

Journal
Journal of Angiotherapy
Published
2024-10-01
DOI
https://doi.org/10.25163/angiotherapy.8109998
Citations
1
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
0.53
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Topical Anti-Inflammatory Formulations from Medicinal Plant Extracts: Stability, Efficacy, and Cytokine Modulation in a Carrageenan-Induced Paw Edema Model

1 citations
Journal of Angiotherapy
Dermatology and Skin Diseases
0.53
article

Topical Anti-Inflammatory Formulations from Medicinal Plant Extracts: Stability, Efficacy, and Cytokine Modulation in a Carrageenan-Induced Paw Edema Model

article en
1 citations

Abstract

Background: Traditional anti-inflammatory drugs, like NSAIDs, often cause side effects, which has fueled interest in plant-based alternatives with fewer adverse effects. Medicinal plants such as turmeric (Curcuma longa), ginger (Zingiber officinale), frankincense (Boswellia serrata), ashwagandha (Withania somnifera), and gotu kola (Centella asiatica) are known for their bioactive compounds with anti-inflammatory properties. This study aimed to evaluate the anti-inflammatory efficacy of these plant extracts in topical formulations. Methods: Ethanol extracts of the selected plants were prepared and formulated into topical gel and cream forms. Stability testing was conducted over a 30-day period to confirm the formulations' consistency, color, and pH. Anti-inflammatory efficacy was assessed using a carrageenan-induced paw edema model in Wistar rats. The animals were divided into six groups, including control, standard drug (indomethacin), and plant-based formulations at two extract concentrations (5% and 10%). Edema reduction was measured using a plethysmometer, and serum cytokine levels (TNF-α and IL-6) were quantified via ELISA. Histopathological analyses of tissue samples further evaluated the anti-inflammatory effects. Results: Both gel and cream formulations demonstrated stability over 30 days. The 10% extract cream formulation achieved the highest reduction in paw edema (70%) and reduced inflammation levels comparable to indomethacin. The 10% extract gel showed similar results (65% reduction). Biochemical analysis revealed significant reductions in TNF-α and IL-6 levels, especially in the 10% cream and gel groups, aligning with histopathological findings that indicated reduced tissue damage and inflammatory cell infiltration in treated groups compared to controls. Conclusion: The findings suggest that these plant extracts possess potent anti-inflammatory effects when formulated into stable, topical products. The 10% extract cream formulation was particularly effective, offering a promising alternative for managing inflammation with fewer side effects.

Journal of AngiotherapyVol. 8(10)
Clean water and sanitation
Openalex Percentile: Top 26%
Dermatology and Skin Diseases
0.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Topical Anti-Inflammatory Formulations from Medicinal Plant Extracts: Stability, Efficacy, and Cytokine Modulation in a Carrageenan-Induced Paw Edema Model · Journal of Angiotherapy (2024) | TGRS Research Map | TGRS